LAWRENCE, Mass., Aug. 15, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, is celebrating Indiana University Health's (IU Health) seventh anniversary of its program to offer home hemodialysis to patients with the NxStage System One™. IU Health started its home dialysis program by partnering with NxStage on its Investigational Device Exemption (IDE) study for U.S. Food and Drug Administration (FDA) clearance to market the System One for home use. In addition, three IU Health patients who were among the first ever to receive dialysis with the System One, are celebrating more than seven years with the therapy.
Long-time dialysis patient Rick Skiles, 57, had tried numerous treatment modalities when he learned about NxStage's clinical trial study at IU Health in 2004. Skiles enrolled and became the first patient in Indiana to train on the NxStage System One. More than seven years later, the flexibility to do his treatments on his own time and the health benefits he has realized thanks to more frequent treatments have helped Skiles lead a liberated, healthy life. "I feel extremely fortunate as a patient at IU Health to have had the opportunity to be among the first daily home hemodialysis patients," says Skiles. "With the System One, I felt I got my life back, and I look forward to many active, healthy years to come with this therapy."
"We applaud healthcare providers and partners such as IU Health for helping to pioneer daily home hemodialysis with the NxStage System One," said Jeffrey H. Burbank, Chief Executive Officer of NxStage Medical. "Because of their leadership, enthusiasm, and continued commitment to advancing renal care, a growing number of dialysis patients like Rick are realizing the life-changing benefits po